News
-
Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
-
BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
-
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
-
NV Gold Announces Non-Brokered Private Placement
-
Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
-
hep global concludes fiscal year 2025 with a positive consolidated result
-
RM plc: Holding(s) in Company
-
Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
-
Amundi Physical Metals plc: UK Final Terms
-
Amundi Physical Metals plc: Final Terms
-
Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
-
Acquisition of Harwanne Capital Management
-
bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
-
Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
-
Successful issue of a € 1.5 billion bond